| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cb70dd12e246e8702b83b3f9c21c602 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9287076a29dc8fc784998e3ad252c38e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51b73c91501d3fc4fec6382c756eb61c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f886a65efbe312e90e84fae45ead9a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f5224839071a12d8678b0b5e8ba10fe |
| publicationDate |
2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103228279-B |
| titleOfInvention |
Injectable liquid composition or injectable drypowder containing revaprazan or its salt |
| abstract |
The present invention provides a liquid composition for injection comprising an inclusion complex of revaprazan or its salt and sulfobutylether-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin in an aqueous medium; and a dry powder for injection obtained by drying the liquid composition for injection. |
| priorityDate |
2010-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |